Cobra Biologics provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.
Looking for trusted specialist media agency with worldwide experience, Cobra selected ib3.
In 2019, Cobra became part of the Cognate BioServices family.
Having worked with Cobra Biologics since 2011, the brief is never the same. Digital media exposure has increased recently. Looking to establish their brand has been key over the years and combining this with a lead generation programme has been an integral part of every brief.
The USA, Europe and Scandinavia are target locations and support for conferences particularly in the USA are vital.
A complete media review and evaluation was undertaken, including meetings with media publishers around the globe. From this a comprehensive media selection document is produced. Looking to increase brand awareness and lead generation opportunities from medium sized Biotech companies, ib3 selected opportunities that offered the best return on investment and value for money. Circulation/readership to the targeted audience was the paramount selection criteria – along with some tough cost negotiations.
A full year campaign was created using print and digital media. Online website banners, enewsletters, specialist forums, content marketing and directories all played a part in the Cobra schedule. USA, Europe and Scandinavian media all selected based on meeting the brief.
ib3 manages all aspects of the campaign from research, evaluation, negotiation, bookings, production management, day to day management, multi-currency invoicing and anything else that is required.
Since 2011 we have worked closely with the whole marketing team at Cobra Biologics to offer a complete end to end service.